The Next Generation Kinase Inhibitors Summit is the only industry-focused conference devoted to using novel kinase biology in drug development and innovating current programs to produce the next generation of kinase inhibitor drugs.
The ECP is the european business speed dating platform for the chemical industry and its processing and user sectors like consumer goods, cosmetics, plastics and adhesives, paints, coatings and varnishes, health, nutrition, flavors, fragrances and analytics…
Adhesives & Bonding Expo Europe is the largest, free trade fair and conference for industrial bonding products and manufacturing on the continent. And, with its co-located sister brand, Foam Expo Europe, it provides visitors with the perfect opportunity for collaboration across the entire supply chain.
Each year CPHI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global market.
Covering the very latest from PROTACs and molecular glues in the clinic, to unveiling next generation strategies including AbTACs, DUBTACs, bioPROTACs, ATACs, RESTORACs and more, this conference provides a prime opportunity to troubleshoot challenging…
As the world‘s leading trade fair for the plastics and rubber industry, K will once again be the global industry highlight of the year for ground-breaking innovations and developments as well as visionary inspiration. Industry and researchers will present trade visitors future perspectives and solutions for the sector.
The Annual DoT event brings back popular topics like PROTACs and RNA plus new programming on immunomodulation, antivirals, neurodegeneration targets, KRAS, and AI.
At the ITHEC Exhibition about 50 market- and technology-leaders will showcase the appropriate materials, machines, solutions and technologies and therefore foster the connection of science and industry.
ChemOutsourcing is the largest USA-based API and Pharmaceutical Ingredients Sept show attracting annually 700-800 customers, project and executive management…
The 2022 programme will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, with a particular attention to current and emerging viral pandemics, but also neurodegenerative and cardiovascular diseases, rare diseases and cancer…